Prohibit dangerous mail-order, do-it-yourself abortions.

Ted Budd · North Carolina · Republican

policy impact 0.74 specificity 0.94 extraction confidence 97%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Occurrences

The candidate commits to back a ban on mail-order self-managed abortions.

Issues - Ted Budd for Senate
campaign · campaign_site · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

Budd joined Senate Republicans in a letter urging HHS and FDA to review approval of generic mifepristone, arguing the drug was being sent by mail and should be reevaluated.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Direct effort against mail-order abortion drugs, but it was advocacy rather than a prohibition or implemented rule.

unresolved later_term A for effort

Letter to HHS and FDA re Mifepristone
secondary · model gpt-5.4-mini · confidence 94%

legacy_unverified · Source version not recorded · locator unknown

In floor remarks, Budd said mifepristone was being mailed without a doctor visit and criticized the Biden administration’s approach to chemical abortion drugs.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Shows continued opposition and attention to the issue in later Senate service, but no enacted prohibition in the lookback window or since.

unresolved later_term A for effort

Congressional Record, Senate, January 14, 2026
secondary · model gpt-5.4-mini · confidence 86%

legacy_unverified · Source version not recorded · locator unknown

Recorded September 9, 2026: 26-30203, State of Louisiana v. FDA; appearing counsel listed; argued September 9, 2026.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): In the lookback window, the Fifth Circuit heard argument in the mifepristone REMS case rather than recording a final prohibition on mail-order abortion drugs. This points to continued litigation, not delivery of Budd's promised federal ban.

unresolved later_term

Oral Argument Recordings - Fifth Circuit
secondary · model gpt-5.5 · confidence 83%

legacy_unverified · Source version not recorded · locator unknown

FDA states mifepristone is approved through ten weeks gestation and, under the REMS, may be dispensed in person or by mail.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The current FDA mifepristone information page still allows dispensing by mail through certified prescribers or certified pharmacies, so the promised prohibition has not been implemented.

never later_term

Information about Mifepristone for Medical Termination of Pregnancy Through Ten Weeks Gestation
secondary · model gpt-5.5 · confidence 92%

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. same_term A for effort

The promised federal prohibition has not been delivered: FDA rules still allow mifepristone to be dispensed by mail through certified prescribers or certified pharmacies, and pending litigation has not produced a final federal ban. Budd did make a serious same-Senate-term effort by cosponsoring S. 4066, the Safeguarding Women from Chemical Abortion Act, and by pressing HHS/FDA through letters and floor remarks, but those actions did not become law or an implemented prohibition.

provider codex_cli · model gpt-5.5 · confidence 90%

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. later_term A for effort

The promised federal outcome was to prohibit mail-order, do-it-yourself abortions, meaning a federal ban or implemented restriction on mailing abortion drugs such as mifepristone. Budd has pursued the issue after winning the 2022 Senate race, including public floor remarks and joining a 2025 letter urging HHS and FDA review of mifepristone, but these actions did not produce an enacted prohibition. As of May 2026, access to mifepristone by mail remains legally available while litigation continues, so the core promised outcome has not been delivered. Because Budd made serious advocacy efforts as a senator, effort credit is warranted, but the outcome remains failed rather than partial or delivered.

provider codex_cli · model gpt-5.5 · confidence 88%